R
Refine Biology
Biotechnology firm that engages in research, development, and manufacturing of natural food ingredients
About Refine Biology
Beijing Refine Biology Co., Ltd. operates as a supplier of natural, healthy food ingredients, providing comprehensive solutions to the food, beverage, and nutrition industries. The company's business is structured around three main product platforms: a natural sweetener platform known as Refine Zero, a botanical extract platform called Refine Natural, and a natural color platform, Refine NaColor. These platforms deliver a range of products, including sweeteners designed to mimic the taste of sucrose with reduced or zero sugar, various botanical extracts for functional demands like immune support and weight management, and coloring foods that provide natural color solutions.
Read full description
The company serves customers across the entire value chain, from ingredients to consumer solutions and food service applications. Its operational infrastructure includes three production bases located in Yangling, Chuzhou, and Qufu, which handle the local manufacturing of its products. These facilities adhere to HACCP and GMP standards and have received FSSC22000, ISO9001, HALAL, and KOSHER certifications. To support its product development, Refine Biology maintains two innovation and research and development labs in Beijing and Shanghai. A significant milestone for the company was being granted the status of a National High and New Technology Enterprise in China in 2020.
Refine Biology's product portfolio under the Refine Natural brand includes extracts from sources such as Rhodiola Rosea, Ginger, Milk Thistle, and Turmeric, which are produced using high-tech extraction technology. Another key offering is D-Mannose, which supports urinary tract health. The company is focused on providing turnkey solutions, which involves developing customized options to meet specific client requirements for appearance, taste, function, and nutrition.
At a glance
- Status
- Operational
- Founded
- 2007
- Headquarters
- Dongcheng District, China
- Employees
- 35
- Open positions
- None listed
- Dealroom signal
- 43.4/100
- Industry
- Health, Food
- Sub-industry
- BioTechnology, Innovative Food
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Refine Biology.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Dec 2025 | $14M | $55M | Xi'an Royal-Power Asset Management · Xingxiang Capital | ↗ |
| SERIES BEquity / VC | Oct 2021 | $14M | $55M | Xingnaher Capital · Cowin Capital | — |
Growth signals
Latest recorded traffic for Refine Biology is 260 monthly website visits, up 85.7% over the last three months. Refine Biology's team grew 6.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Challenjers- XCXingnaher Capital
Cowin Capital
Series B and later2 investors entered at this stage
- XCXingxiang Capital
- XMXi'an Royal-Power Asset Management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Refine Biology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Refine Biology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.